.Antibody-drug conjugates (ADCs) have actually been at the center of numerous a billion-dollar biobuck licensing bargain over the last year, but Bivictrix Rehabs believes that
Read moreBiopharma layoff fee maintains in Q3: Brutal Biotech study
.As summer months heat energy counts on cool winds, wishes that this year will take prevalent field relief have frittered away, with quarterly cutbacks night
Read moreBiopharma Q2 VC struck highest level given that ’22, while M&A decreased
.Financial backing financing right into biopharma cheered $9.2 billion all over 215 sell the second fourth of this particular year, connecting with the highest possible
Read moreBiogen’s CEO said no unsafe deals in 2023. He prepares to be vibrant
.While Biogen’s pharma peers are seeking for late-stage resources with little threat, chief executive officer Chris Viehbacher desires to bring in even more early-stage medicines,
Read moreBiogen cans SAGE-324 partnership after crucial shake stop working
.Biogen has carried out the last rites to its cooperation with Sage Rehabs on SAGE-324, junking the partnership in the after-effects of an unsuccessful research
Read moreBiogen bows out Denali Alzheimer’s collab
.Biogen has actually handed back civil rights to a very early Alzheimer’s disease plan to Denali Therapies, leaving a large hole in the biotech’s cooperation
Read moreBiogen, UCB record phase 3 lupus succeed after stopping working earlier test
.Biogen as well as UCB’s bet one’s bottom dollar developing into period 3 on the back of a broken study seeks to have actually settled,
Read moreBiogen CMO Maha Radhakrishnan signs up with Sofinnova– Chutes & Ladders
.Invite to today’s Chutes & Ladders, our roundup of significant management hirings, shootings as well as retirings across the sector. Satisfy send the compliment– or
Read moreBioMarin standstills preclinical genetics therapy for heart condition
.After BioMarin carried out a spring season clean of its pipe in April, the provider has actually determined that it likewise needs to unload a
Read moreBioMarin goes CAMPing, striking RNA handle biotech
.BioMarin is actually including kindling to the R&D fire, assaulting a suit with CAMP4 Rehabs for legal rights to choose 2 aim ats recognized due
Read more